Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases.
Conclusions: Clinicians may encounter difficulties when treating PTB in patients with RD. Despite the favorable long-term outcomes of RD patients, the outcomes of individual patients such as those with systemic lupus erythematosus (SLE) should be interpreted with caution during post-therapy follow-up.
PMID: 31903246 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
More News: Arthritis | Autoimmune Disease | Drugs & Pharmacology | Gastroenterology | Lupus | Respiratory Medicine | Rheumatoid Arthritis | Rheumatology | South Korea Health | Study | Tuberculosis